Lung Cancer Clinical Trials in Raleigh, NC

Lung Cancer Clinical Trials in Raleigh, NC

View the best 10 lung cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Lung Cancer clinical trial.

Trials in Raleigh, North Carolina

Here are the top 10 medical studies for lung cancer in Raleigh, North Carolina

Image of Alabama Oncology Bruno Cancer Center ( Site 0001) in Birmingham, United States.

Pembrolizumab

PD-1 Inhibitor

Recruiting2 awardsPhase 3
This trial is comparing two treatment combinations for a specific type of lung cancer. It aims to find out which combination helps patients live longer and keeps their cancer from getting worse. The treatments work by boosting the immune system, making it harder for cancer cells to repair themselves, or stopping their growth.
Image of Millennium Research & Clinical Development in Houston, United States.

Ifinatamab Deruxtecan (I-DXd)

Antibody-Drug Conjugate

Recruiting1 awardPhase 2
This trial tests a new drug, ifinatamab deruxtecan (I-DXd), on patients with a specific type of lung cancer who have not responded to other treatments. The drug aims to target and kill cancer cells.
Image of I.H.S Health, LLC in Kissimmee, United States.

Treatment

Verified
Recruiting1 award4 criteria
This trial is testing a blood test to see if it can detect lung cancer early in high-risk individuals. Blood samples will be collected from participants who are getting a routine CT scan for lung cancer screening.
Image of Research Site in Phoenix, United States.

Pemetrexed +4 More

Chemotherapy

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment combining a drug called durvalumab with chemotherapy. The study will compare how well the new treatment works compared to chemotherapy alone.
Image of Duke University Medical Center in Durham, United States.

GT103

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is testing a new cancer drug to see what dose is safe and effective.
Image of UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco, United States.

9-ING-41

GSK-3β inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective in treating cancer. The drug is designed to target a protein called GSK-3β, which is found in many different types of cancer cells.
Image of UNC Lineberger Comprehensive Cancer Center in Chapel Hill, United States.

CAR-macrophages

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial is testing a new cancer treatment involving CAR macrophages (a type of white blood cell) and HER2 overexpressing solid tumors (a type of cancer).
Image of Research Site in Tucson, United States.

Durvalumab

Recruiting1 awardPhase 3
This trial is testing whether Durvalumab alone or with Tremelimumab can help patients with a specific type of lung cancer who have already had initial treatment. The drugs aim to boost the immune system to fight off any remaining cancer cells. Durvalumab and Tremelimumab are being studied together for their potential to improve cancer treatment outcomes.
Image of University of California, San Francisco in San Francisco, United States.

Gavo-cel (TC-210)

CAR T-cell Therapy

Recruiting2 awardsPhase 1 & 2
This trial is testing a new cell therapy that consists of T cells that have been genetically engineered to express a single-domain antibody that recognizes human Mesothelin. The T cells are fused to the CD3-epsilon subunit, which is incorporated into the endogenous T cell receptor (TCR) complex. The aim of the trial is to establish the recommended Phase 2 dose and to evaluate the efficacy of the therapy in patients with advanced mesothelin-expressing cancers.
Image of Virginia Commonwealth University in Richmond, United States.

Patient Navigation

Recruiting1 award6 criteria
This trial tested if a patient navigation program improved the proportion of patients who completed lung cancer screening (LDCT).

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.